MedTrace Logo

BLYS and IFN in SLE

NCT00611611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2011-04-28

No results posted yet for this study

Summary

This protocol tests whether changes in BLyS or IFN can be detected in a normal immune response to a vaccine and, if so, whether the response differs between those with lupus and healthy controls.

Conditions

Interventions

BIOLOGICAL

fluzone

once

BIOLOGICAL

pneumovax

once

Sponsors & Collaborators

  • Hospital for Special Surgery, New York

    collaborator OTHER

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Robert H Carter, MD · University of Alabama at Birmingham

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00611611 on ClinicalTrials.gov